Discover
INSM
Insmed Incorporated
108.62
1 x 107.51
1 x 110.49
bid
ask
+
1.60
1.50%
25 @ 04:00 PM
110.50 +1.88 (1.73%)
| Ytd | -37.59% | |
| 1y | 5.54% |
106.41
day range
109.42
90.39
52 week range
212.75
| Open | 107.87 | Prev Close | 107.02 | Low | 106.41 | High | 109.42 | Mkt Cap | 23.54B |
| Vol | 2.45M | Avg Vol | 3.83M | EPS | -5.75 | P/E | -18.89 | Forward P/E | 16.37 |
| Beta | 0.78 | Short Ratio | 3.20 | Inst. Own | 105.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 105.79 | 200-d Avg | 149.85 | 1yr Est | 196.38 |
| Income Statement | |||
| Total Revenue | 305.96M | ||
| Revenues (USD) | 305.96M | ||
| Cost of Revenue | 47.42M | ||
| Gross Profit | 258.54M | ||
| Operating Expenses | 458.83M | ||
| Research and Development Expense | 209.49M | ||
| Selling, General and Administrative Expense | 247.26M | ||
| Operating Income | -200.28M | ||
| Interest Expense | 20.08M | ||
| Income Tax Expense | 1.47M | ||
| Net Income | -163.56M | ||
| Net Income Common Stock | -163.56M | ||
| Net Income Common Stock (USD) | -163.56M | ||
| Consolidated Income | -163.56M | ||
| Earnings per Basic Share | -0.76 | ||
| Earnings per Basic Share (USD) | -0.76 | ||
| Earnings per Diluted Share | -0.76 | ||
| Earning Before Interest & Taxes (EBIT) | -142.02M | ||
| Earning Before Interest & Taxes (USD) | -142.02M | ||
| Weighted Average Shares | 215.47M | ||
| Weighted Average Shares Diluted | 215.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 582.19M | ||
| Cash and Equivalents (USD) | 582.19M | ||
| Investments | 641.33M | ||
| Investments Current | 641.33M | ||
| Trade and Non-Trade Receivables | 178.56M | ||
| Current Assets | 1.61B | ||
| Property, Plant & Equipment Net | 131.73M | ||
| Total Assets | 2.08B | ||
| Debt Current | 8.45M | ||
| Total Debt | 742.46M | ||
| Current Liabilities | 361.01M | ||
| Debt Non-Current | 734.01M | ||
| Total Liabilities | 1.37B | ||
| Accumulated Retained Earnings (Deficit) | -5.80B | ||
| Accumulated Other Comprehensive Income | 4.00K | ||
| Shareholders Equity | 704.85M | ||
| Shareholders Equity (USD) | 704.85M | ||
| Assets Non-Current | 462.69M | ||
| Total Debt (USD) | 742.46M | ||
| Goodwill and Intangible Assets | 231.68M | ||
| Inventory | 132.91M | ||
| Liabilities Non-Current | 1.01B | ||
| Trade and Non-Trade Payables | 352.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.58M | ||
| Net Cash Flow from Financing | 29.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 71.74M | ||
| Capital Expenditure | -3.48M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -15.00M | ||
| Issuance (Purchase) of Equity Shares | 30.31M | ||
| Issuance (Repayment) of Debt Securities | -799.00K | ||
| Net Cash Flow from Investing | 265.52M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 284.00M | ||
| Net Cash Flow from Operations | -222.74M | ||
| Effect of Exchange Rate Changes on Cash | -553.00K | ||
| Share Based Compensation | 45.75M | ||